U.S. flag An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Improving Access to Overdose Treatment

Open Date:

1/23/2023

Close Date:

3/24/2023

Upcoming Milestones:

Anticipated Award Date August 31,2023 and start date September 30, 2023

Eligible Recipients:

  • Non-profit
  • Private Sector

Program Purpose:

  • Health and Safety

Reserved for Energy
Communities?

No

Funded by:

U.S. Department of Health and Human Services

Overview

The purpose of this program is to expand access to naloxone and other Food and Drug Administration (FDA) approved overdose reversal medications for emergency treatment of known or suspected opioid overdose. The recipients will collaborate with other prescribers at the community level to implement trainings on policies, procedures, and models of care for prescribing, co-prescribing, and expanding access to naloxone and other FDA-approved overdose reversal medications to the specified population of focus (i.e., rural or urban).

Related Resources

Additional information is available on the Resources page.

Funding Details

Funding Source:
Funding Type:
Grant - no match
Total Amount Available:
$1400000.00
Limit per Applicant:
$200,000
Estimated Awards:
7

Applicant Guidance

Contact Information

Program Issues:

Kristen K. Harper

Center for Substance Abuse Prevention

Division of Targeted Prevention

Substance Abuse and Mental Health Services Administration

(240) 276-2420

[email protected]

Grants Management and Budget Issues

Office of Financial Resources, Division of Grants Management

Substance Abuse and Mental Health Services Administration

(240) 276-1400

[email protected]

Scroll to Top